Erythema multiforme
ICD-10 L51 · ICD-11 EB12
Treatment of Erythema Multiforme Caused by a Recent Medication
This protocol covers erythema multiforme in which a recently introduced medication has been identified as the causative trigger, presenting without mucosal involvement and without evidence of concurrent infection.
Clinical scenario
When a causative drug is identified, addressing that trigger is the critical first step. This skin-limited presentation — without mucosal spread or infectious aetiology — defines the specific management context covered here.
Treatment approach (partial overview)
Management begins with removing the offending agent. Depending on symptom burden, a topical or oral symptomatic option may then be considered — the complete selection criteria, sequencing, and clinical decision points are contained in the full protocol.
Treatment goal
Regression of erythema multiforme skin lesions
References
DOI: 10.3390/medicina57090921
- Similarly, if there is evidence that the EM is caused by a medication, discontinuing the medication is the initial step.
- Stop drug; use topical corticosteroids or antihistamines for symptomatic disease.
- Once the etiology has been addressed, acute EM can be managed with topical steroids or antihistamines, if needed to improve symptoms.
- In acute disease, treatment is rarely needed as the lesions will typically regress over the course of several weeks, and supportive treatment is focused on improving symptoms.